Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy
ACS Nano · 29.10.2024 · 18 (43) · 29439-29456
DOI: 10.1021/acsnano.3c12337 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 15.10.2024. Verfasst von Sheng-Liang Cheng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan. Hauptthemen laut MEDLINE: Membrane Proteins, Immunotherapy, Hydrogels, Nucleotides, Cyclic. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Health Research Institutes, National Tsing Hua University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu 30013, Taiwan.
- International Intercollegiate Ph.D. Program, National Tsing Hua University, Hsinchu 30013, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
- Division of Clinical Skills Training, Department of Medical Education, Taipei Veterans General Hospital, Taipei 11217, Taiwan.
- Therapeutic and Research Center of Pancreatic Cancer, Veterans General Hospital, Taipei 11217, Taiwan.
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
ORCID-Profile: Ting-Wen Chen, Dehui Wan, Yunching Chen
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Health Research Institutes
- National Tsing Hua University
Zitieren
APA
Cheng, S. L., Lee, H. M., Li, C. P., Lin, M. W., Chou, M. Y., Yen, Y. T., Wu, T. H., Lian, Y. C., Shih, Y. C., Chiang, C. S., Chen, T. W., Wan, D., & Chen, Y. (2024). Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy. ACS Nano, 18(43), 29439-29456. https://doi.org/10.1021/acsnano.3c12337
Vancouver
Cheng SL, Lee HM, Li CP, Lin MW, Chou MY, Yen YT, et al. Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy. ACS Nano. 2024;18(43):29439-29456. doi:10.1021/acsnano.3c12337
BibTeX
@article{Cheng2024,
author = {Cheng, Sheng-Liang and Lee, Hsin-Mei and Li, Chung-Pin and Lin, Mei-Wei and Chou, Min-Yuan and Yen, Yu-Ting and Wu, Tun-Han and Lian, Yun-Chen and Shih, Yu-Chuan and Chiang, Chi-Shiun and Chen, Ting-Wen and Wan, Dehui and Chen, Yunching},
title = {Robust and Sustained STING Pathway Activation via Hydrogel-Based In Situ Vaccination for Cancer Immunotherapy},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {43},
pages = {29439--29456},
doi = {10.1021/acsnano.3c12337}
}
EUVIMED